Technical Analysis for PDLI - PDL BioPharma, Inc.

Grade Last Price % Change Price Change
grade D 2.96 -0.67% -0.02
PDLI closed down 0.67 percent on Friday, May 24, 2019, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical PDLI trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 200 DMA Bearish -0.67%
Hammer Candlestick Bullish -0.67%
Narrow Range Bar Range Contraction -0.67%
NR7 Range Contraction -0.67%
NR7-2 Range Contraction -0.67%
Oversold Stochastic Weakness -0.67%

Older signals for PDLI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.
Biotechnology Cancer Life Sciences Antibodies Monoclonal Antibodies Antibody Humanized Antibody
Is PDLI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.89
52 Week Low 2.25
Average Volume 1,251,952
200-Day Moving Average 3.0042
50-Day Moving Average 3.4672
20-Day Moving Average 3.1775
10-Day Moving Average 3.047
Average True Range 0.1123
ADX 45.18
+DI 8.9509
-DI 24.8727
Chandelier Exit (Long, 3 ATRs ) 3.0931
Chandelier Exit (Short, 3 ATRs ) 3.2469
Upper Bollinger Band 3.4721
Lower Bollinger Band 2.8829
Percent B (%b) 0.13
BandWidth 18.54288
MACD Line -0.1402
MACD Signal Line -0.1278
MACD Histogram -0.0124
Fundamentals Value
Market Cap 456.07 Million
Num Shares 154 Million
EPS 0.44
Price-to-Earnings (P/E) Ratio 6.73
Price-to-Sales 3.18
Price-to-Book 0.56
PEG Ratio 0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.14
Resistance 3 (R3) 3.14 3.09 3.11
Resistance 2 (R2) 3.09 3.04 3.09 3.10
Resistance 1 (R1) 3.02 3.01 3.00 3.02 3.09
Pivot Point 2.97 2.97 2.95 2.97 2.97
Support 1 (S1) 2.90 2.92 2.88 2.90 2.83
Support 2 (S2) 2.85 2.89 2.85 2.82
Support 3 (S3) 2.78 2.85 2.81
Support 4 (S4) 2.78